High-throughput platform for rapid deployment of antimicrobial agents

Area of Science:

• Microbiology
• Biotechnology
• Materials Science

Background:

• Bacterial infections pose a significant global health threat.
• Developing novel antimicrobial agents is crucial to combat rising antibiotic resistance.
• Targeting bacterial surface components like lipopolysaccharide (LPS) is a promising strategy.

Purpose of the Study:

• To develop a high-throughput method for identifying bacterial binding peptides.
• To investigate the potential of these peptides as antimicrobial agents.
• To explore the use of nanoparticle scaffolds for enhanced antibacterial activity.

Main Methods:

• Utilized an addressable high-density random sequence peptide microarray for bacterial binding assays.
• Performed competitive inhibition assays using bacterial lipopolysaccharide (LPS).
• Analyzed the amino acid composition of selected peptides.
• Conjugated selected peptides to polyvalent nanoparticle scaffolds.

Main Results:

• The peptide microarray effectively identified bacterial binding peptides.
• Bacterial binding was significantly inhibited by LPS, indicating LPS as the primary target.
• Selected peptides shared amino acid composition similarities with natural antimicrobial peptides.
• Peptide-nanoparticle conjugates demonstrated potent antibacterial agglutination activity.

Conclusions:

• A novel peptide microarray approach enables efficient identification of bacterial LPS-targeting peptides.
• These peptides show promise as a new class of antimicrobial agents.
• Nanoparticle conjugation enhances the antibacterial efficacy of these peptides, offering a versatile platform for developing agents against diverse pathogens.